Ildong Pharmaceutical Co., Ltd. (249420.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In KRW
| Market Cap | 1.16T |
| Enterprise Value | 1.24T |
| P/E Ratio | 14.64 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 0.91 |
| Price/Book Ratio | 1.88 |
| Enterprise/Revenue | 1.1 |
| Enterprise/EBITDA | 14.05 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.06 |
| Operating Margin | 0.04 |
| Return On Assets | 0.06 |
| Return On Equity | 0.16 |
| Revenue | 566.93B |
| Revenue/Share | 20,301.66 |
| Gross Profit | 214.76B |
| EBITDA | 39.9B |
| Net Income | 27.66B |
| Diluted EPS | 936.77 |
| Total Cash | 59.07B |
| Total Cash/Share | 2,093.04 |
| Total Debt | 144.55B |
| Total Debt/Equity | 0.58 |
| Current Ratio | 0.99 |
| Book Value Per Share | 8,502.47 |
| 52-Week Change | 30.96 |
| 52-Week High | 45,050 |
| 52-Week Low | 12,400 |
| Moving Average 50 Days | 23,341 |
| Moving Average 200 Days | 29,493.25 |
| Average Volume | 199,767 |
| Shares Outstanding | 31.51M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 200 |
| Trailing Annual Dividend Yield | 1.21 |
| Payout Ratio | 0 |
| Last Split Factor | 21:20 |
| Last Split Date | March 05, 2020 |